Screener / SEC EDGAR /CIK 0000730464 /10-K filed Aug 6, 2026, compared with Aug 7, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Consumer discretionary · Educational Services

Covista Inc. CVSA

Compare with peers Embed
New in the 10-K 16 paragraphs with nothing like them in the 10-K filed Aug 7, 2025 New in the 10-Q 31 paragraphs not in the 10-Q filed May 7, 2026 10-Q against the 10-K 0 risk factor paragraphs and sentences added or reworded

New risk paragraphs, branching off last year

Each branch is a paragraph in Risk Factors with nothing like it in the 10-K filed Aug 7, 2025. A box jumps to the paragraph as filed, below.

16 new

Paragraphs with nothing like them in last year's 10-K

Quoted exactly

16 paragraphs in Risk Factors of the 10-K filed Aug 6, 2026 with nothing like them in the 10-K filed Aug 7, 2025. Quoted exactly. Paragraphs that were only edited are under 10-K change.

affected. Management cannot predict all the possible risks and uncertainties that may arise. Risks and uncertainties that may affect Covista’s business include the following:

Read in the 10-K

Due to the regulatory and enforcement efforts at times directed at all Title IV participating institutions and adverse publicity arising from such efforts, we may face additional government and regulatory investigations and actions, lawsuits from private plaintiffs, and shareholder class actions and derivative claims. We may incur significant costs and other

Read in the 10-K

Recent changes to federal student loan programs that reduce annual, aggregate, and lifetime borrowing limits and limit federal student aid for part-time students may limit students’ ability to finance their education, which may in turn materially and adversely affect our results of operations.

There have been recent changes to federal student loan programs under the HEA, including the imposition of new annual, aggregate, and lifetime borrowing limits across multiple loan programs, eliminating or restricting certain loan options previously available to graduate and professional students such as Grad PLUS, and limiting federal student aid for part-time students. Many of these changes took effect July 1, 2026, with certain provisions applying prospectively to new borrowers, subject to further implementation through ED regulations and guidance.

These changes may materially reduce the amount of loan funding available to students. Students who are unable to access sufficient federal loan funds may be required to rely more heavily on personal savings, private loans, or other sources of financing, which may be unavailable, more expensive, or less predictable. As a result, some prospective students

may choose not to enroll, delay enrollment, enroll part-time, select shorter or lower-cost programs, or discontinue their studies before completion. Other students may choose to enroll full-time to avoid part-time Title IV limits.

Any sustained reduction in students’ ability or willingness to finance their education through federal loan programs could materially reduce student enrollments, persistence, and completion rates, and adversely affect our revenue, operating results, and growth prospects. We are informing prospective students about private financing alternatives available in the market. We cannot predict the extent to which reduced federal loan availability may influence prospective student demand.

Read in the 10-K

In addition, if one of our Title IV institutions were to close, we could be subject to liabilities arising from closed school discharge claims. Under applicable regulations, students who do not complete their programs due to a qualifying institutional closure may be eligible for loan discharges, and ED may seek to recover the amount of such discharges from the institution or, in certain circumstances, from other institutions under common ownership. Any such liabilities could be material and could adversely affect our business, financial condition, results of operations, and cash flows.

Read in the 10-K

If we, or one of the companies that service our credit programs, do not comply with laws applicable to the financing programs that assist our students in affording our educational offerings, including Truth in Lending and Fair Debt

Read in the 10-K
Show the other 2

Our future effective tax rates may be subject to volatility due to a number of factors, including the geographic mix of earnings, with lower than expected income in jurisdictions with favorable tax rates and higher than expected income in higher tax jurisdictions; changes in the valuation of deferred tax assets and liabilities; the expiration, modification, or lapses of various tax law provisions; the tax treatment of stock-based compensation; and costs associated with intercompany transactions or business restructurings. In addition, changes in tax rates, laws, regulations, accounting principles, or interpretations thereof could further impact our tax position.

Read in the 10-K

Increased use of artificial intelligence (“AI”) in our programs and processes or by others may subject us to increased business, compliance, and legal risk.

We use and are working to further incorporate AI technologies into our operations, products, and services. While we expect that our use of AI will help grow our business and benefit our students and employees, it is not certain that we will realize our desired or anticipated benefits. Any actual or perceived misuse of AI technologies could adversely affect student trust, our reputation, and our business results.

Our development and use of AI may require additional investments and/or increase the cost of our operations and offerings and increase our reliance on third-party vendors and service providers. Any failure, disruption, security incident, or misconduct involving such providers may adversely affect our operations and financial condition.

The presence of AI could increase our legal risk due to the rapidly evolving legal and regulatory landscape governing AI. Compliance with existing and future AI-related laws and regulations may increase our cost of compliance, restrict our ability to deploy certain AI-enabled solutions, and may result in legal or reputational exposure in the event of actual or alleged noncompliance.

Other postsecondary institutions may more successfully and quickly integrate AI as a means to facilitate business growth, reduce operating expenses, and improve the student experience, which may result in a material adverse effect on our business or operations.

We may be required to make substantial investments in content creation, digital marketing, search optimization, AI optimization strategies, technology, personnel, and third-party service providers to maintain or improve visibility across emerging AI-enabled platforms. There can be no assurance that these investments will be successful or that we will be able to keep pace with technological change.

Read in the 10-K

Paragraphs in the 10-Q filed Oct 29, 2026 that were not in the one before

New in the latest 10-Q

31 paragraphs in the 10-Q filed Oct 29, 2026 with nothing like them in the 10-Q filed May 7, 2026 (at least half the words must differ; new numbers alone do not count). Quoted exactly, grouped by the item heading above them. This is text that changed, not a judgement of how serious it is.

Financial statements and notes

Three Months Ended September 30, 2026 2025 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Revenue $ 511,534 $ 462,288 Operating cost and expense: Cost of educational services 220,759 200,767 Student services and administrative expense 192,585 175,734 Restructuring expense 163 310 Total operating cost and expense 413,507 376,811 Operating income 98,027 85,477 Interest expense (9,944) (11,090) Other income, net 1,416 2,486 Income from continuing operations before income taxes 89,499 76,873 Provision for income taxes (18,017) (15,811) Income from continuing operations 71,482 61,062 Discontinued operations: (Loss) income from discontinued operations before income taxes (5,420) 747 Benefit from income taxes 1,365 23 (Loss) income from discontinued operations (4,055) 770 Net income and comprehensive income $ 67,427 $ 61,832 Earnings (loss) per share: Basic: Continuing operations $ 2.11 $ 1.69 Discontinued operations $ (0.12) $ 0.02 Total basic earnings per share $ 1.99 $ 1.71 Diluted: Continuing operations $ 2.07 $ 1.65 Discontinued operations $ (0.12) $ 0.02 Total diluted earnings per share $ 1.95 $ 1.67 Weighted-average shares outstanding: Basic shares 33,951 36,111 Diluted shares 34,573 37,057

Read in the 10-Q

Arrangements for payment are agreed to prior to registration of the student’s first academic term. The majority of U.S. students obtain Title IV or other financial aid resulting in institutions receiving a significant amount of the transaction price at the beginning of the academic term. Students not utilizing Title IV or other financial aid funding may pay after the academic term is complete.

Read in the 10-Q

and Other Benefits Medical and Veterinary $ 44 $ — $44 Home Office 145 121 266 Total $ 189 $ 121 $310

Read in the 10-Q

Three Months Ended September 30, 2026 2025 ───────────────────────────────────────────────────────────────────────────────────────────────── Numerator: Net income (loss): Continuing operations $ 71,482 $61,062 Discontinued operations (4,055) 770 Net income $ 67,427 $61,832 Denominator: Weighted-average basic shares outstanding 33,951 36,111 Effect of dilutive stock awards 622 946 Weighted-average diluted shares outstanding 34,573 37,057 Earnings (loss) per share: Basic: Continuing operations $ 2.11 $1.69 Discontinued operations $ (0.12) $0.02 Total basic earnings per share $ 1.99 $1.71 Diluted: Continuing operations $ 2.07 $1.65 Discontinued operations $ (0.12) $0.02 Total diluted earnings per share $ 1.95 $1.67 Weighted-average antidilutive shares — —

Read in the 10-Q

Curriculum is a finite-lived intangible asset that is amortized on a straight-line basis. Curriculum amortization expense was $1.4 million and $2.8 million in the three months ended September 30, 2026 and 2025, respectively. Curriculum was fully amortized as of August 12, 2026.

Read in the 10-Q
Show the other 26

Indefinite-lived intangible assets related to trade names and Title IV eligibility and accreditations are not amortized, as there are no legal, regulatory, contractual, economic, or other factors that limit the useful life of these intangible assets to the reporting entity.

Read in the 10-Q

Goodwill and indefinite-lived intangible assets are not amortized, but are reviewed for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is May 31.

Read in the 10-Q

During the first quarter of fiscal year 2027, Covista performed an assessment to determine whether there were indicators of a triggering event which could indicate the carrying value of the reporting units may not be supported by the fair value. No indicators of a triggering event for potential impairment were noted in the first quarter of fiscal year 2027.

Read in the 10-Q

If economic conditions deteriorate or operating performance of our reporting units does not meet expectations such that we revise our long-term forecasts, we may recognize impairments of goodwill and other intangible assets in future periods.

Read in the 10-Q

Unamortized debt discount and issuance costs as of June 30, 2026 $10,150 $4,570 $14,720

Read in the 10-Q

Unamortized debt discount and issuance costs as of September 30, 2026 $9,769 $4,291 $14,060

Read in the 10-Q

Interest Expense Interest expense consisted of the following (in thousands): Three Months Ended September 30, 2026 2025 ───────────────────────────────────────────────────────────────────────────────────────────────────────────── Term Loan B interest expense $ 7,782 $ 2,775 Notes interest expense - 5,568 Loss on debt extinguishment - 295 Amortization of debt discount and issuance costs 660 850 Letters of credit fees 1,151 1,276 Other 351 326 Total $ 9,944 $ 11,090 Covenants and Guarantees The Credit Agreement contains customary covenants, including restrictions on our restricted subsidiaries’ ability to merge and consolidate with other companies, incur indebtedness, grant liens or security interest on assets, make acquisitions, loans, advances or investments, or sell or otherwise transfer assets. Obligations under the Credit Agreement are secured by a first-priority lien on substantially all of the assets of Covista and certain of its domestic wholly-owned subsidiaries. The Credit Agreement contains customary events of default for facilities of this type. If an event of default under the Credit Agreement occurs and is continuing, the commitments thereunder may be terminated and the principal amount outstanding thereunder, together with all accrued and unpaid interest and other amounts owed thereunder, may be declared immediately due and payable. With respect to the Revolver, the terms of the Credit Agreement require Covista to maintain a Total Net Leverage Ratio (as defined in the Credit Agreement) equal to or less than 3.25 to 1.00. Covista was in compliance with the Credit Agreement debt covenants as of September 30, 2026. Off-Balance Sheet Arrangements As of September 30, 2026, Covista had $ 202.6 million in surety-backed letters of credit outstanding in favor of the U.S. Department of Education (“ED”) with an expiration date of September 30, 2027. The letters of credit represent 10 % of the consolidated Title IV funds Covista’s institutions received during fiscal year 2025. As of September 30, 2026, Covista had $85.0 million of surety bonds to satisfy certain state regulatory requirements for licensure. 14. Share Repurchases The Covista Board of Directors (the “Board”) has authorized several share repurchase programs. Most recently, on December 15, 2025, we announced that the Board authorized Covista’s sixteenth share repurchase program, which allows Covista to repurchase up to $750.0 million of its common stock through December 15, 2028. Covista made share repurchases under its share repurchase programs as follows (in thousands, except shares and per share data): Three Months Ended September 30, 2026 2025 ─────────────────────────────────────────────────────────────────────────────────────── Total number of share repurchases 658,088 56,817 Total cost of share repurchases $ 83,990 $7,594 Average price paid per share $ 127.63 $133.66 As of September 30, 2026, $577.8 million of authorized share repurchases remained under the sixteenth share repurchase program. The timing and amount of any future repurchases will be determined based on an evaluation of market conditions and other factors. These repurchases may be made through open market purchases, accelerated share

Read in the 10-Q

Beginning in fiscal year 2023, the Compensation Committee of the Board determined to no longer grant stock options. Prior to fiscal year 2023, we granted stock options generally with a four-year graded vesting from the grant date that expire ten years from the grant date. The following table summarizes stock option activity for the three months ended September 30, 2026:

Read in the 10-Q

Weighted-Average Number of Remaining Aggregate Stock Weighted-Average Contractual Life Intrinsic Value Options Exercise Price (in years) (in thousands) Outstanding as of June 30, 2026 271,614 $ 38.08 Outstanding as of September 30, 2026 271,614 38.08 4.2 $ 22,847 Exercisable as of September 30, 2026 271,614 $ 38.08 4.2 $ 22,847

Read in the 10-Q

As of June 30, 2026, all stock options were vested. Therefore, no stock options vested during the three months ended September 30, 2026 and there is no remaining unrecognized stock-based compensation expense related to unvested stock options as of September 30, 2026. The fair value of stock options that vested during the three months ended September 30, 2025 was $0.6 million. The total intrinsic value of stock options exercised for the three months ended September 30, 2025 was $0.4 million. There were no stock options exercised during the three months ended September 30, 2026.

Read in the 10-Q

We grant RSUs generally with a three-year graded vesting from the grant date. We also grant RSUs to our Board members with a one-year cliff vest from the grant date. The fair value per share of RSUs is the closing market price of our common stock on the grant date. The following table summarizes RSU activity for the three months ended September 30, 2026:

Read in the 10-Q

The weighted-average grant date fair value per share of RSUs granted in the three months ended September 30, 2026 and 2025 was $116.41 and $117.85, respectively. The grant date fair value of RSUs that vested during the three months

Read in the 10-Q

Covista has elected not to measure any assets or liabilities at fair value other than those required to be measured at fair value on a recurring basis. Equity investments without readily determinable fair values are accounted for under the measurement alternative, under which the carrying value is adjusted for observable price changes and impairments recognized through net income.

Read in the 10-Q

Summary financial information by reportable segment is as follows (in thousands): Three Months Ended September 30, 2026 2025 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Revenue: Chamberlain $ 192,400 $ 179,201 Walden 216,673 189,960 Medical and Veterinary 102,461 93,127 Consolidated $ 511,534 $ 462,288 Cost of educational services: Chamberlain $ 93,304 $ 83,198 Walden 74,069 64,752 Medical and Veterinary 53,386 52,817 Other segment expenses(1): Chamberlain $ 72,366 $ 70,395 Walden 77,561 69,134 Medical and Veterinary 26,824 23,538 Adjusted operating income: Chamberlain $ 26,730 $ 25,608 Walden 65,043 56,074 Medical and Veterinary 22,251 16,772 Total segment adjusted operating income 114,024 98,454 Reconciliation to Consolidated Financial Statements: Home Office expense (7,453) (8,178) Restructuring expense (163) (310) Amortization of acquired intangible assets (1,394) (2,805) Strategic advisory costs (6,231) (1,684) Debt modification costs (756) - Consolidated operating income 98,027 85,477 Interest expense (9,944) (11,090) Other income, net 1,416 2,486 Consolidated income from continuing operations before income taxes $ 89,499 $ 76,873 Depreciation: Chamberlain $ 6,094 $ 5,375 Walden 1,784 1,940 Medical and Veterinary 2,823 2,820 Home Office 161 161 Consolidated $ 10,862 $ 10,296 Amortization of acquired intangible assets: Walden $ 1,394 $ 2,805 Consolidated $ 1,394 $ 2,805 (1) Other segment expenses for each reportable segment include student services and administrative related expenses.

Read in the 10-Q

Fiscal Year 2027 Semester Sept. 2026 Total students 5,481 % change from prior year 3.5% Fiscal Year 2026 Semester Sept. 2025 Jan. 2026 May 2026 Total students 5,297 5,344 5,120 % change from prior year 2.4% 4.1% 7.3%

Read in the 10-Q

education-related support activities, and provision for credit losses. The following table presents information regarding cost of educational services (in thousands):

Read in the 10-Q

(1) Consolidated results include Home Office activities not allocated to segments.

Read in the 10-Q

Chamberlain and Medical and Veterinary operate physical campus locations and therefore incur costs associated with maintaining and operating those campuses. In contrast, Walden primarily delivers education through an online model and does not incur campus-related operating costs. As a result, the operating margins of Chamberlain and Medical and Veterinary historically have been lower than those of Walden.

Read in the 10-Q

Three Months Ended September 30, 2026 2025 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Diluted earnings per share (GAAP) $ 1.95 $ 1.67 Effect on diluted earnings per share: Restructuring expense 0.00 0.01 Amortization of acquired intangible assets 0.04 0.08 Strategic advisory costs 0.18 0.05 Loss on debt extinguishment and debt modification costs 0.02 0.01 U.S. tax benefit due to an increase in foreign-derived income (0.06) - Income tax impact on non-GAAP adjustments(1) (0.06) (0.03) Loss (income) from discontinued operations 0.12 (0.02) Adjusted earnings per share (non-GAAP) $ 2.19 $ 1.75 Diluted shares 34,573 37,057

Read in the 10-Q

(1) Consolidated results include Home Office activities not allocated to segments.

Read in the 10-Q

Other information

On September 14, 2026, Mr. Stephen W. Beard, Covista’s Chairman and Chief Executive Officer, adopted a 10b5-1 Preset Diversification Program (the “New 10b5-1 Plan”). Mr. Beard’s New 10b5-1 Plan is a continuation of his current 10b5-1 Plan entered into on December 10, 2025, which expires on November 30, 2026 (the “Current Plan”). The New 10b5-1 Plan provides for the sale of Covista common stock that has not been sold under Mr. Beard’s Current Plan. Mr.

Read in the 10-Q

Beard’s New 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Beard’s New 10b5-1 Plan are subject to the required “cooling-off” period with the estimated first sale date under Mr. Beard’s New 10b5-1 Plan to occur not before December 15, 2026, after the expiration of his Current Plan. Mr. Beard’s New 10b5-1 Plan expires on May 28, 2027. The New 10b5-1 Plan governs Mr. Beard’s sale of 112,859 shares of Covista common stock. After such sales, Mr. Beard would continue to satisfy the stock ownership requirements for our executive officers. Transactions under the New 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.

Read in the 10-Q

On September 14, 2026, Mr. Robert Phelan, Covista’s Senior Vice President and Chief Financial Officer, adopted a 10b5-1 Plan. Mr. Phelan’s 10b5-1 Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c). Trades under Mr. Phelan’s 10b5-1 Plan are subject to the required “cooling-off period” with the estimated first sale date under Mr. Phelan’s 10b5-1 Plan to occur not before December 15, 2026. Mr. Phelan’s 10b5-1 Plan expires on September 24, 2027. The 10b5-1 Plan governs Mr. Phelan’s sale of 22,000 shares of Covista common stock. After such sales, Mr. Phelan would continue to satisfy the stock ownership requirements for our executive officers. Transactions under the 10b5-1 Plan will be disclosed publicly through Form 144 and Form 4 filings with the SEC to the extent required by law.

Read in the 10-Q

In accordance with applicable SEC rules, the following is intended to satisfy Covista’s Item 5.02 Form 8-K reporting obligations by making timely disclosure in accordance with Item 5(a) of Form 10-Q.

Read in the 10-Q

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Read in the 10-Q

On October 27, 2026, Mr. Robert J. Phelan, Covista’s Senior Vice President and Chief Financial Officer, as well as its principal financial officer, informed Covista of his intention to retire from these positions after nearly seven years, as part of a planned transition. Mr. Phelan will continue to serve in these roles until his successor is named, with no change in responsibilities. Mr. Phelan will support the incoming Chief Financial Officer through a transition period. Covista has initiated a search for Mr. Phelan’s successor. Mr. Phelan will continue to receive his current compensation and benefits for which he is eligible during this period. The terms of Mr. Phelan’s compensation arrangements in connection with his retirement from Covista have not yet been finalized. Covista will disclose any material terms in a future filing with the SEC once finalized.

Read in the 10-Q

The 10-Q's risk factors against the 10-K

Item 1A of the 10-Q filed Oct 29, 2026 against Item 1A of the 10-K filed Aug 6, 2026. A 10-Q repeats only the risks that changed, so a 10-K paragraph that is missing from it is not counted as removed. Added is a paragraph with nothing like it in the 10-K, Reworded a sentence that is in both with several words changed, Quiet changes a sentence in both where one to four words changed and one is a hedge or a modal (cut words struck through, new words highlighted). Text on the page, not a score; each links to the filing at sec.gov.

What the 10-Q itself says about its risk factors:There have been no material changes to Covista’s risk factors from those set forth since Item 1A. “Risk Factors” contained in our 2026 Form 10-K.

Read in the 10-Q

1 paragraph in the 10-Q's Item 1A, and none of them adds, rewords or quietly edits a paragraph of the 10-K's.

Phrases used for the first time

Two-word phrases in Risk Factors of the 10-K filed Aug 6, 2026 that are in none of the 1 earlier 10-Ks stored, back to Aug 7, 2025

loan programs ×4federal loan ×3covista’s common ×2covista’s title ×2federal education ×2education assistance ×2assistance funds ×2annual aggregate ×2lifetime borrowing ×2borrowing limits ×2student aid ×2part-time students ×2students ability ×2across multiple ×2disruptions armed ×2armed conflicts ×2
Where each one is used
  • loan programs: Recent changes to federal student loan programs that reduce annual, aggregate, and lifetime borrowing limits and limit federal student aid for part-time students may limit students’ ability to finance their education, which may in turn materially and adversely affect our results of operations.
  • federal loan: These changes may materially reduce the amount of loan funding available to students. Students who are unable to access sufficient federal loan funds may be required to rely more heavily on personal savings, private loans, or other sources of financing, which may be unavailable, more expensive, or less predictable....
  • covista’s common: Covista’s business operations are subject to numerous risks and uncertainties, some of which are not entirely within our control. Investors should carefully consider the risk factors described below and all other information contained in this Annual Report on Form 10-K before making an investment decision with...
  • covista’s title: Due to the regulated nature of proprietary postsecondary institutions, we are subject to audits, compliance reviews, inquiries, complaints, investigations, claims of non-compliance, and lawsuits by federal and state governmental agencies, regulatory agencies, accrediting agencies, present and former students and...
  • federal education: Our Title IV institutions collectively receive 78% of their revenue from Federal education assistance funds. As a result, any reductions in funds available to our students or any delays in payments to us under Title IV and other Federal programs could have a material adverse effect on our business, financial...
  • education assistance: Our Title IV institutions collectively receive 78% of their revenue from Federal education assistance funds. As a result, any reductions in funds available to our students or any delays in payments to us under Title IV and other Federal programs could have a material adverse effect on our business, financial...
  • assistance funds: Our Title IV institutions collectively receive 78% of their revenue from Federal education assistance funds. As a result, any reductions in funds available to our students or any delays in payments to us under Title IV and other Federal programs could have a material adverse effect on our business, financial...
  • annual aggregate: Recent changes to federal student loan programs that reduce annual, aggregate, and lifetime borrowing limits and limit federal student aid for part-time students may limit students’ ability to finance their education, which may in turn materially and adversely affect our results of operations.

The 10-K at sec.gov

Used at least twice, small words left out. Counted, not picked: a phrase can be new because the company renamed something.

What was taken out

4 paragraphs of last year's Risk Factors with nothing like them now. The longest are quoted.

Across all companies
Our Board authorized a share repurchase program pursuant to which we may repurchase up to $150.0 million of our common stock through May 6, 2028. As of June 30, 2025, $150.0 million of authorized share repurchases were remaining under this share repurchase program. The manner, timing, and amount of any share repurchases may fluctuate and will be determined by us based on a variety of factors, including the market price of our common stock, our priorities for the use of cash to support our business operations and plans, general business and market conditions, tax laws, and alternative...
In the 10-K filed Aug 7, 2025
volatility of the price of our common stock, or reduce our available cash balance. Our share repurchase program may be modified, suspended, or terminated at any time, which may result in a decrease in the trading prices of our common stock. Even if our share repurchase program is fully implemented, it may not enhance long-term stockholder value.
In the 10-K filed Aug 7, 2025
We cannot guarantee that our share repurchase program will be utilized to the full value approved or that it will enhance long-term stockholder value. Repurchases we consummate could increase the volatility of the price of our common stock and could have a negative impact on our available cash balance.
In the 10-K filed Aug 7, 2025
We are currently analyzing the changes made by OBBBA and what effect they may have on Adtalem.
In the 10-K filed Aug 7, 2025

Sources

Item 1A of each 10-K and 10-Q on EDGAR, quoted exactly. Each paragraph links to the filing at sec.gov.

Also

10-K change: what was reworded or cut, section by section.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CVSA/export.csv") into a cell.

Next:10-K change
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.